VitroScan Shares ChemoPredict Journey at Biotech Booster Annual Event

11 March 2026

VitroScan took the stage at the annual Biotech Booster event to share insights from the journey of its ChemoPredict project, highlighting the pathway from scientific discovery to real-world patient impact. During the session, CEO Willemijn Vader and Joris Schuurmans, Chair of ChemoPredict’s Project Steering Committee, reflected on the project’s progress, discussing both key successes and the challenges of translating cutting-edge research into a market-ready product. A central theme of the discussion was the value of strong governance and expert guidance. The session underscored how collaboration within the Biotech Booster framework and the support of a highly experienced Project Steering Committee helps accelerate innovation on the path from science to patients. 🚀🧬